Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
Journal of the American Academy of Dermatology | Sep 20, 2017
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis
Journal of the American Academy of Dermatology | Sep 20, 2017
|Fragility of epidermis: Acne and post-procedure lesional skin
Journal of the European Academy of Dermatology and Venereology | Sep 20, 2017
Serious infections among a large cohort of subjects with systemically treated psoriasis
Journal of the American Academy of Dermatology | Sep 19, 2017
Psoriasis and suicidality: A systematic review and meta-analysis
Journal of the American Academy of Dermatology | Sep 19, 2017
|Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population based cohorts: 1989 â 2009
Journal of the European Academy of Dermatology and Venereology | Sep 19, 2017
An empirically generated responder definition for rosacea treatment
Clinical, Cosmetic and Investigational Dermatology | Sep 19, 2017